Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

133%

4 of 3 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 4

3(60.0%)

N/A

1(20.0%)

Phase 1

1(20.0%)

5Total

Phase 4(3)

N/A(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT00934661Phase 4Terminated

Low Dose Extended-release Epidural and Lumbar Plexus Block Compared to Lumbar Plexus Block for Total Hip Resurfacing

Role: collaborator

NCT00895531Phase 4Terminated

Combination of Peripheral Nerve Block and DepoDur in Total Knee Joint Replacement

Role: collaborator

NCT00765648Phase 4Completed

Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department

Role: collaborator

NCT00335517Not ApplicableCompleted

Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients

Role: collaborator

NCT00728832Phase 1Completed

A Pharmacokinetic (PK) Study of Extended-Release Epidural Morphine in Upper Abdominal Surgery

Role: lead

All 5 trials loaded